ALPINE IMMUNE SCIENCES, INC. Quarterly Current Income Tax Expense (Benefit) in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2024.
  • Alpine Immune Sciences, Inc. Current Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
  • Alpine Immune Sciences, Inc. annual Current Income Tax Expense (Benefit) for 2023 was -$51K, a 102% decline from 2022.
  • Alpine Immune Sciences, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $2.28M, a 1669% increase from 2021.
  • Alpine Immune Sciences, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $129K.
Current Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q2 2022 $1.3M Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-14
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.